#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5105160	B	Inhibition of His-tagged Mycobacterium tuberculosis H37Rv InhA expressed in Escherichia coli BL21 using 2-trans-dodecenoyl-CoA as substrate incubated for 30 mins in presence of NADH by fluorescence based assay	Mycobacterium tuberculosis	2		assay format	Scientific Literature
2.	ALA5105161	F	Cytotoxicity against human HepG2 cells assessed as cell growth inhibition incubated for 72 hrs by Cell Titer Glo assay	Homo sapiens	2		cell-based format	Scientific Literature
3.	ALA5105162	F	Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 25618 assessed as bacterial growth inhibition incubated for 5 days by fluorescence based assay	Mycobacterium tuberculosis	2		organism-based format	Scientific Literature
4.	ALA5105163	A	Oral bioavailability in CD-1 mouse at 10 mg/kg	Mus musculus	1		organism-based format	Scientific Literature
5.	ALA5105164	A	Protein binding in human serum	Homo sapiens	1		cell-free format	Scientific Literature
6.	ALA5105165	A	Protein binding in mouse plasma	Mus musculus	1		cell-free format	Scientific Literature
7.	ALA5139585	F	Antibacterial activity against Mycobacterium tuberculosis Erdman (TMCC 107) assessed as reduction in resistance generation frequency	Mycobacterium tuberculosis	1		organism-based format	Scientific Literature
8.	ALA5139604	F	Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 5 days	Mycobacterium tuberculosis	2		organism-based format	Scientific Literature
9.	ALA5139605	F	Antibacterial activity against Mycobacterium tuberculosis Erdman in acute Mtb infection C57BL/6-IFN-gamma-tm1Ts KO mouse model assessed as reduction in log10 CFU in lungs at 50 mg/kg, po qd for 9 consecutive days	Mycobacterium tuberculosis	1		organism-based format	Scientific Literature
10.	ALA5139608	B	Inhibition of His-tagged Mycobacterium tuberculosis H37Rv InhA expressed in Escherichia coli BL21 (DE3) incubated for 30 mins by fluorescence based assay	Mycobacterium tuberculosis	1		assay format	Scientific Literature
11.	ALA5139609	F	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability treated for 72 hrs by Cell Titer Glo assay	Homo sapiens	1		cell-based format	Scientific Literature
12.	ALA5139610	A	Half life in CD-1 mouse at 5 mg/kg, iv measured for 24 hrs	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA5139611	A	Oral bioavailability in CD-1 mouse at 10 mg/kg measured for 24 hrs	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA5139612	F	Antibacterial activity against Mycobacterium tuberculosis Erdman (TMCC 107) in chronic Mtb infection BALB/c mouse model assessed as reduction in log10 CFU in lungs at 100 mg/kg, po via gavage upto 8 weeks	Mycobacterium tuberculosis	1		organism-based format	Scientific Literature
15.	ALA5139613	F	Antibacterial activity against Mycobacterium tuberculosis Erdman (TMCC 107) in Mtb infection C3HeB/FeJ mouse model assessed as reduction in log10 CFU in lungs at 100 mg/kg, po via gavage upto 4 weeks	Mycobacterium tuberculosis	1		organism-based format	Scientific Literature
16.	ALA5139614	F	Antibacterial activity against Mycobacterium tuberculosis Erdman (TMCC 107) in Mtb infection C3HeB/FeJ mouse model assessed as reduction in resistance generation frequency administered for 8 weeks relative to control	Mycobacterium tuberculosis	2		organism-based format	Scientific Literature
17.	ALA5139618	F	Antibacterial activity against extensively drug-resistant Mycobacterium tuberculosis clinical isolate assessed as inhibition of bacterial growth in presence of SMARt-420	Mycobacterium tuberculosis	1		organism-based format	Scientific Literature
18.	ALA5139619	F	Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis clinical isolate assessed as inhibition of bacterial growth in presence of SMARt-420	Mycobacterium tuberculosis	1		organism-based format	Scientific Literature